Cash Equivalents - Perseus Proteomics Inc (TSE:4882) - Alpha Spread

Perseus Proteomics Inc
TSE:4882

Watchlist Manager
Perseus Proteomics Inc Logo
Perseus Proteomics Inc
TSE:4882
Watchlist
Price: 588 JPY 1.03% Market Closed
Market Cap: 8.7B JPY
Have any thoughts about
Perseus Proteomics Inc?
Write Note

Perseus Proteomics Inc
Cash Equivalents

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Perseus Proteomics Inc
Cash Equivalents Peer Comparison

Comparables:
2160
4587
4974
S
4599
C
4894

Competitive Cash Equivalents Analysis
Latest Figures & CAGR of Competitors

Company Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
Perseus Proteomics Inc
TSE:4882
Cash Equivalents
ÂĄ1.5B
CAGR 3-Years
13%
CAGR 5-Years
7%
CAGR 10-Years
N/A
GNI Group Ltd
TSE:2160
Cash Equivalents
ÂĄ16.3B
CAGR 3-Years
6%
CAGR 5-Years
21%
CAGR 10-Years
13%
PeptiDream Inc
TSE:4587
Cash Equivalents
ÂĄ25.5B
CAGR 3-Years
29%
CAGR 5-Years
30%
CAGR 10-Years
22%
Takara Bio Inc
TSE:4974
Cash Equivalents
ÂĄ38B
CAGR 3-Years
6%
CAGR 5-Years
14%
CAGR 10-Years
5%
S
StemRIM Inc
TSE:4599
Cash Equivalents
ÂĄ10.2B
CAGR 3-Years
-1%
CAGR 5-Years
41%
CAGR 10-Years
N/A
C
Cuorips Inc
TSE:4894
Cash Equivalents
ÂĄ5.6B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Perseus Proteomics Inc's Cash Equivalents?
Cash Equivalents
1.5B JPY

Based on the financial report for Mar 31, 2024, Perseus Proteomics Inc's Cash Equivalents amounts to 1.5B JPY.

What is Perseus Proteomics Inc's Cash Equivalents growth rate?
Cash Equivalents CAGR 5Y
7%

Over the last year, the Cash Equivalents growth was -37%. The average annual Cash Equivalents growth rates for Perseus Proteomics Inc have been 13% over the past three years , 7% over the past five years .

Back to Top